FRANKFURT, April 6 German drugs-packaging firm
Gerresheimer on Thursday said its major pharmaceutical
customers had been more cautious in placing orders due to
uncertainty over the new U.S. administration's policies.
Revenues at its business division that makes glass bottles
and vials for drugs fell 2.9 percent in its fiscal first quarter
through the end of February as sales in North America slipped,
Overall revenues were down more than 5 percent at 302.8
million euros ($323.1 million), missing analyst consensus of 307
million euros in a Reuters poll.
The group stuck with full-year guidance for revenues at the
lower end of a range from 1.405 billion to 1.455 billion euros.
Analysts on average see 2017 revenues of 1.43 billion euros.
($1 = 0.9371 euros)
(Reporting by Maria Sheahan; Editing by Himani Sarkar)